Pfizer and BioNTech’s COVID Vaccine Hits 90% Effectiveness
US pharma giant Pfizer and German biotech BioNTech have delivered a massive breakthrough in the race for a coronavirus vaccine. Their jab has shown to be 90% effective at stopping people from catching Covid-19.
First Vaccine to Show Real Results
This jab is one of around a dozen vaccines worldwide in the final testing stage, but it’s the first to reveal such promising results. The two firms revealed this after an interim analysis of their phase 3 trials.
Massive Supply Plans to Follow
- Trial involved 43,538 volunteers across six countries
- Participants received two doses: vaccine or placebo
- Results show 90% protection within 28 days of the jab
- Pfizer and BioNTech plan to supply 50 million doses by the end of 2020
- They aim to produce 1.3 billion doses globally by the end of 2021
This is a game-changer in the fight against coronavirus, offering hope millions could be protected soon. The world watches as Pfizer and BioNTech edge closer to ending the pandemic.
